Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients.
De Bruyne, Elke; Andersen, T. L.; De Raeve, Hendriket al.
Caers, Jo ; Université de Liège - ULiège > Hématologie clinique
Van Camp, Ben
Delaisse, J. M.
Van Riet, Ivan
Vanderkerken, Karin
Language :
English
Title :
Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients.
Caligaris-Cappio F, Bergui L, Gregoretti MG, Gaidano G, Gaboli M, Schena M et al. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 1991; 77: 2688-2693.
Lokhorst HM, Lamme T, de Smet M, Klein S, de Weger RA, van Oers R et al. Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood 1994; 84: 2269-2277.
Kuehl WM, Bergsagel PL. Multiple myeloma: Evolving genetic events and host interactions. Nat Rev Cancer 2002; 2: 175-187.
Menu E, Asosingh K, Van Riet I, Croucher P, Van Camp B, Vanderkerken K. Myeloma cells (5TMM) and their interactions with the marrow environment. Blood Cells Mol Dis 2004; 33: 111-119.
Bakkus MHC, Heirman C, Van Riet I, Van Camp B, Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 1992; 80: 2326-2335.
Martin F, Roth DM, Jans DA, Pouton CW, Partrigde LJ, Monl PN et al. Tetraspanins in viral infections: A fundamental role in viral biology? J Virol 2005; 79: 10839-10851.
Boucheix C, Duc GH, Jasmin C, Rubinstein E. Tetraspanins and malignancy. Expert Rev Mol Med 2001, 1-17.
Wright MD, Moseley GW, van Spriel AB. Tetraspanin microdomains in immune cell signalling and malignant disease. Tissue Antigens 2004; 64: 533-542.
Si Z, Hersey P. Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely correlated to metastatic potential of melanoma. Int J Cancer 1993; 54: 37-43.
Miyake M, Nakano K, Leki Y, Adachi M, Huang CL, Itoi S et al. Motility related protein 1 (MRP-1/CD9) expression: Inverse correlation with metastases in breast cancer. Cancer Res 1995; 55: 4127-4131.
Adachi M, Taki T, Konishi T, Huang CI, Higashiyama M, Miyake M. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression. J Clin Oncol 1998; 16: 1397-1406.
Mori M, Mimori K, Shiraishi T, Haraguchi M, Ueo H, Barnard GF et al. Motility related protein 1 (MRP1/CD9) expression in colon cancer. Clin Cancer Res 1998; 4: 1507-1510.
Houle CD, Ding XY, Foley JF, Afshari CA, Barrett JC, Davis BJ. Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian progression. Gynecol Oncol 2002; 86: 69-78.
Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 1993; 177: 1231-1237.
Miyake M, Inufusa H, Adachi M, Ishida H, Hashida H, Tokuhara T et al. Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery. Oncogene 2000; 19: 5221-5226.
Kubista B, Erovic BM, Klinger H, Sulzbacher I, Trieb K. CD9 expression is not a prognostic factor in human osteosarcoma. Cancer Lett 2004; 209: 105-110.
Jamil F, Peston D, Shousha S. CD9 immunohistochemical staining of breast carcinoma: Unlikely to provide useful prognostic information for routine use. Histopathology 2001; 39: 572-577.
Sauer G, Windisch J, Kurzeder V, Heilmann V, Kreienberg R, Deissler H. Progression of cervical carcinoma is associated with down-regulation of CD9 but strong re-expression on sites of transendothelial invasion. Clin Cancer Res 2003; 9: 6426-6431.
Barrena S, Almeida J, Yunta M, Lopez A, Fernandez-Mosteirin N, Giralt M et al. Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation. Leukemia 2005; 19: 1376-1383.
Drucker L, Tohami T, Tartakover-Matalon S, Zismanov V, Shapiro H, Radnay J et al. Promoter hypermethylation of tetraspanin members contributes to their silencing in myeloma cell lines. Carcinogenesis 2006; 27: 197-204.
Radl J, De Glopper E, Schuit HRE. Idiopathic paraproteinemia II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. J Immunol 1979; 122: 609-613.
Vanderkerken K, Asosingh K, Croucher P, Van Camp B. Multiple myeloma biology: Lessons from the 5TMM models. Immunol Rev 2003; 194: 196-206.
Vanderkerken K, De Raeve H, Goes E, Van Meirvenne S, Radl J, Van Riet I et al. Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. Br J Cancer 1997; 76: 451-460.
De Raeve H, Asosingh K, Wisse E, Van Camp B, Van Marck E, Vanderkerken K. Part of the multiple myeloma-associated microvessels is functionally connected to the systemic circulation: A study in the murine 5T33MM model. Virchows Archiv 2004; 445: 389-395.
Van Valckenborgh E, Bakkus M, Munaut C, Noel A, St Pierre Y, Asosingh K et al. Upregulation of matrix metalloproteinase-9 (MMP-9) in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cell. Int J Cancer 2002; 101: 512-518.
Imai K, Kobayashi M, Wang J, Ohiro Y, Hamada J, Cho Y et al. Selective transendothelial migration of hematopietic progenitor cells: A role in homing of progenitor cells. Blood 1999; 93: 149-156.
Van Riet I, De Greef C, Aharchi F, Woischwill C, De Waele M, Bakkus M et al. Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stromaindependent variant (MM5.2). Leukemia 1997; 11: 284-293.
Menu E, Asosingh K, Indraccolo S, De Raeve H, Van Riet I, Van Valckenborgh E et al. The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model. Haematologica 2006; 91: 605-612.
Zhu D, van Arkel C, King CA, van Meirvenne S, de Greef C, Thielemans K et al. Immunoglobulin VH gene sequence analysis of spontaneous murine immunoglobulin-secreting B-cell tumors with clinical features of human disease. Immunology 1998; 93: 162-170.
Van Valckenborgh E, De Raeve H, Devy L, Blacher S, Munaut C, Noel A et al. Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo. Br J Cancer 2002; 86: 796-802.
Oritani K, Wu X, Medina K, Hudson J, Miyake K, Gimble JM et al. Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood 1996; 87: 2252-2261.
Oka M, Tagoku K, Russell TL, Nakano Y, Hamazaki T, Meyer EM et al. CD9 is associated with leukaemia inhibitory factor-mediated maintenance of embryonic stem cells. Mol Biol Cell 2002; 13: 1274-1281.
Tanio Y, Yamazaki H, Kunisada T, Miyake K, Hayashi SI. CD9 molecule expressed on stromal cells is involved in osteoclastogenesis. Exp Hematol 1999; 27: 853-859.
Stojanovic M, Germain M, Nguyen M, Shore GC. BAP13 and its caspase cleavage product regulate cell surface expression of the tetraspanins and integrin-mediated cell survival. J Biol Chem 2005; 280: 30018-30024.
Baudoux B, Castanares-Zapatero D, Leclerq-Smekens M, Berna N, Poumay Y. The tetraspanin CD9 associates with the integrin á6â4 in cultured human epidermal keratinocytes and is involved in cell motility. Eur J Cell Biol 2000; 79: 41-51.
Dery MA, Michaud MD, Richard DE. Hypoxia-inducible factor 1: Regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 2005; 37: 535-540.
Bouchel C, Benoit P, Frachet P, Billard M, Worthington RE, Gagnon J et al. Molecular cloning of the CD9 antigen. J Biol Chem 1991; 266: 117-122.
Asosingh K, De Raeve H, Van Riet I, Van Camp B, Vanderkerken K. Multiple myeloma tumor progression in the 5T2MM murine model is a multistage and dynamic process of differentiation, proliferation, invasion and apoptosis. Blood 2003; 101: 3136-3141.
Turker M. Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene 2002; 21: 5388-5393.
Asosingh K, Günthert U, Bakkus MHC, De Raeve H, Goes E, Van Riet I et al. In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells. Cancer Res 2000; 60: 3096-3104.
Longo N, Yáñes-Mó M, Mittelbrunn M, de la Rosa G, Munoz ML, Sánchez-Madrid F et al. Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells. Blood 2001; 98: 3717-3726.
